FasterCures, a Center of the Milken Institute, is pleased to see the inclusion of $1 billion in funding for a new Advanced Research Projects Agency for Health (ARPA-H) in the omnibus FY22 spending bill recently passed. We have long supported the deployment of DARPA-like authorities and capabilities for more high-risk, solutions-oriented medical research and development. We are gratified that this concept is moving forward at a time when the critical importance of fast-paced, collaborative, cutting-edge science is front and center in the attention of policymakers and the public.
Securing this funding is a critical step, and we look forward to engaging with Congress in developing and passing authorizing legislation needed to equip ARPA-H with the tools required for the new agency to be effective in achieving its mission to drive solutions to health challenges of high unmet need and low innovation activity.

Esther Krofah
Related Content
-
FasterCures mobilizes for next phase of work to save lives by improving the global medical R&D system, launches health data initiative
WASHINGTON, October 22, 2018 – FasterCures, the Milken Institute center whose mission is to save lives by speeding medical breakthroughs to patients, is announcing new initiatives to engage the private sector, strengthen global partnerships...Read Article -
Milken Institute Statement on the Passage of the FY2023 Omnibus Appropriations Package
The Milken Institute applauds Congress on the passage of the FY2023 Omnibus Appropriations bill. The package includes key health and finance provisions championed by the Milken Institute that will strengthen the biomedical research...Read Statement -
Silver to Gold: The Business of Aging
Opportunities presented by an aging population will not be fully realized unless business leaders act now to prepare for this irreversible shift in demography. To discuss the significance of population aging for the business sector and...Read Report -
Neurotechnology: A Giving Smarter Guide
When most people think about advances in medicine, drug development is the first thing that comes to mind. However, technology and devices are proving to be valuable options for treating intractable illnesses. Technological solutions in the...Read Report11
-
The Impact of Insight: Patient Preferences in Novel Screening Technologies for Cancer
Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product life cycle can create meaningful results...Patient preferences and insights are increasingly considered throughout the medical product life cycle in addition to clinical outcomes. We know that incorporating patient preferences in the product...
11Katie O'Connor and Hadly Clark -
What Kills Americans: Growth of Metabolic Contributors
The most common way to understand the impact of a disease is to track its rates of prevalence and mortality because these metrics are derived from easily collected data. However, prevalence and mortality rates fail to capture whether a...View Research -
Milken Institute Launches COVID-19 Vaccine and Treatment Tracker
Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...Read Article -
FDA Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products, and Devices
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spring, MD 20993 Dear Dr. Califf, FasterCures is pleased to offer comments on FDA’s draft guidance on Decentralized Clinical Trials for Drugs...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Towards Successful Aging in Asia
Countries undergoing population aging today are facing a much different experience than their historical counterparts. One only needs to look at the countries in Asia to see how these trends are unfolding. Demographic aging is happening...Read Report -
Models for Financing Antibiotic Development to Address Antimicrobial Resistance
The Financial Innovations Labs® and FasterCures teams have collaborated on a project to identify new models for financing the antimicrobial resistant antibiotic pipeline. These past 18 months have demonstrated how consequential public...Read Report11
-
Catalyzing Action for Pharmacist-Provided Food Is Medicine Care
"Catalyzing Action for Pharmacist-Provided Food Is Medicine Care" provides background, insights, and actionable recommendations for pharmacies and key partners, including health-care payers and policymakers, to scale FIM interventions in...Read Report -
Improving Early Detection of Cognitive Impairment and Dementia
DOWNLOAD REPORT The prevalence of mild cognitive impairment (MCI) and dementia is increasing as advancements in medicine, public health, and living standards extend human lifespans. Approximately 12–18 percent of Americans aged 60 and older...Read Report11 11
Diane Ty, Soo Borson, MD, and Katie Partrick, PhD